Tags

Type your tag names separated by a space and hit enter

Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.
Pharmacol Ther. 2017 Dec; 180:62-76.P&T

Abstract

Eicosanoids are biologically active lipid signaling molecules derived from polyunsaturated fatty acids. Many of the actions of eicosanoid metabolites formed by cyclooxygenase and lipoxygenase enzymes have been characterized, however, the epoxy-fatty acids (EpFAs) formed by cytochrome P450 enzymes are newly described by comparison. The EpFA metabolites modulate a diverse set of physiologic functions that include inflammation and nociception among others. Regulation of EpFAs occurs primarily via release, biosynthesis and enzymatic transformation by the soluble epoxide hydrolase (sEH). Targeting sEH with small molecule inhibitors has enabled observation of the biological activity of the EpFAs in vivo in animal models, greatly contributing to the overall understanding of their role in the inflammatory response. Their role in modulating inflammation has been demonstrated in disease models including cardiovascular pathology and inflammatory pain, but extends to neuroinflammation and neuroinflammatory disease. Moreover, while EpFAs demonstrate activity against inflammatory pain, interestingly, this action extends to blocking chronic neuropathic pain as well. This review outlines the role of modulating sEH and the biological action of EpFAs in models of pain and inflammatory diseases.

Authors+Show Affiliations

Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA 95616, United States.Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA 95616, United States.EicOsis LLC, Davis, CA 95618, United States.Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA 95616, United States. Electronic address: bdhammock@ucdavis.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

28642117

Citation

Wagner, Karen M., et al. "Soluble Epoxide Hydrolase as a Therapeutic Target for Pain, Inflammatory and Neurodegenerative Diseases." Pharmacology & Therapeutics, vol. 180, 2017, pp. 62-76.
Wagner KM, McReynolds CB, Schmidt WK, et al. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol Ther. 2017;180:62-76.
Wagner, K. M., McReynolds, C. B., Schmidt, W. K., & Hammock, B. D. (2017). Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacology & Therapeutics, 180, 62-76. https://doi.org/10.1016/j.pharmthera.2017.06.006
Wagner KM, et al. Soluble Epoxide Hydrolase as a Therapeutic Target for Pain, Inflammatory and Neurodegenerative Diseases. Pharmacol Ther. 2017;180:62-76. PubMed PMID: 28642117.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. AU - Wagner,Karen M, AU - McReynolds,Cindy B, AU - Schmidt,William K, AU - Hammock,Bruce D, Y1 - 2017/06/19/ PY - 2017/6/24/pubmed PY - 2018/7/7/medline PY - 2017/6/24/entrez KW - Alzheimer's disease KW - Depression KW - Epoxy-fatty acids (EpFAs) KW - Inflammatory pain KW - Neuropathic pain KW - Soluble epoxide hydrolase (sEH) SP - 62 EP - 76 JF - Pharmacology & therapeutics JO - Pharmacol. Ther. VL - 180 N2 - Eicosanoids are biologically active lipid signaling molecules derived from polyunsaturated fatty acids. Many of the actions of eicosanoid metabolites formed by cyclooxygenase and lipoxygenase enzymes have been characterized, however, the epoxy-fatty acids (EpFAs) formed by cytochrome P450 enzymes are newly described by comparison. The EpFA metabolites modulate a diverse set of physiologic functions that include inflammation and nociception among others. Regulation of EpFAs occurs primarily via release, biosynthesis and enzymatic transformation by the soluble epoxide hydrolase (sEH). Targeting sEH with small molecule inhibitors has enabled observation of the biological activity of the EpFAs in vivo in animal models, greatly contributing to the overall understanding of their role in the inflammatory response. Their role in modulating inflammation has been demonstrated in disease models including cardiovascular pathology and inflammatory pain, but extends to neuroinflammation and neuroinflammatory disease. Moreover, while EpFAs demonstrate activity against inflammatory pain, interestingly, this action extends to blocking chronic neuropathic pain as well. This review outlines the role of modulating sEH and the biological action of EpFAs in models of pain and inflammatory diseases. SN - 1879-016X UR - https://www.unboundmedicine.com/medline/citation/28642117/Soluble_epoxide_hydrolase_as_a_therapeutic_target_for_pain_inflammatory_and_neurodegenerative_diseases_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0163-7258(17)30154-7 DB - PRIME DP - Unbound Medicine ER -